首页> 外文OA文献 >The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

【2h】

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

机译：HCV根除后肝细胞癌发展的风险在用peg-干扰素加利巴韦林和直接作用抗病毒治疗的患者之间是相似的。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yuko Nagaoki; Michio Imamura; Hiroshi Aikata; Kana Daijo; Yuji Teraoka; Fumi Honda; Yuki Nakamura; Masahiro Hatooka; Reona Morio; Kei Morio; Hiromi Kan; Hatsue Fujino; Tomoki Kobayashi; Keiichi Masaki; Atsushi Ono; Takashi Nakahara; Tomokazu Kawaoka; Masataka Tsuge; Akira Hiramatsu; Yoshiiku Kawakami; C Nelson Hayes; Daiki Miki; Hidenori Ochi; Kazuaki Chayama;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Low serum zinc concentration is a risk for development of hepatocellular carcinoma and oral zinc supplementation decreases its risk in patients with HCV eradication by direct-acting antivirals [J] . Hosui Atsushi, Hiramatsu Naoki Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：低血清锌浓度是肝细胞癌发育的风险，口服锌补充剂通过直接作用抗病毒验证的HCV消除患者的风险降低
2. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection [J] . Degasperi Elisabetta, DAmbrosio Roberta, Iavarone Massimo, Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2019,第6期

机译：肝硬化患者患者对HCV感染的直效抗病毒治疗的肝硬化患者风险增加的因素
3. Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals [J] . Debes Jose D., van Tilborg Marjolein, Groothuismink Zwier M. A., Gastroenterology . 2018,第3期

机译：用直接作用抗病毒治疗HCV感染患者肝细胞癌患者血清患者细胞因子水平
4. Impact of single nucleotide polymorphism of TGF-β1 gene (SNP-codon10) on hepatocellular carcinoma risk in Egyptian patients following HCV infection [C] . Magdy El Bordiny, Shaden Hanafy, Alaa Abdo WSEAS International Conference on Environment, Ecosystems and Development . 2013

机译：TGF-β1基因单核苷酸多态性（SNP-Codon10）对HCV感染后埃及患者肝细胞癌风险的影响
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy [O] . Yuko Nagaoki, Michio Imamura, Hiroshi Aikata, -1

机译：钉-干扰素联合利巴韦林和直接作用抗病毒治疗的患者之间HCV根除后肝细胞癌发展的风险相似
7. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection [O] . Elisabetta Degasperi, Roberta D’Ambrosio, Massimo Iavarone, 2019

机译：肝硬化患者患者对HCV感染的直效抗病毒治疗的肝硬化患者风险增加的因素

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

著录项

相似文献

相关主题

期刊订阅